GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bide Pharmatech Co Ltd (SHSE:688073) » Definitions » Profitability Rank

Bide Pharmatech Co (SHSE:688073) Profitability Rank : 5 (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Bide Pharmatech Co Profitability Rank?

Bide Pharmatech Co has the Profitability Rank of 5.

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way. It is based on these factors:

1. Operating Margin %
2. Piotroski F-Score
3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.
4. Consistency of the profitability
5. Predictability Rank

Bide Pharmatech Co's Operating Margin % for the quarter that ended in Mar. 2024 was 11.86%. As of today, Bide Pharmatech Co's Piotroski F-Score is 4.


Competitive Comparison of Bide Pharmatech Co's Profitability Rank

For the Drug Manufacturers - Specialty & Generic subindustry, Bide Pharmatech Co's Profitability Rank, along with its competitors' market caps and Profitability Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bide Pharmatech Co's Profitability Rank Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bide Pharmatech Co's Profitability Rank distribution charts can be found below:

* The bar in red indicates where Bide Pharmatech Co's Profitability Rank falls into.



Bide Pharmatech Co Profitability Rank Calculation

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Bide Pharmatech Co has the Profitability Rank of 5.

Profitability Rank is not directly related to the Financial Strength. But if a company is consistently profitable, its financial strength will be stronger.

Profitability Rank is based on these factors:

1. Operating Margin %

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Bide Pharmatech Co's Operating Margin % for the quarter that ended in Mar. 2024 is calculated as:

Operating Margin %=Operating Income (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=31.159 / 262.67
=11.86 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

2. Piotroski F-Score

The zones of discrimination were as such:

Good or high score = 8 or 9
Bad or low score = 0 or 1

Bide Pharmatech Co has an F-score of 4 indicating the company's financial situation is typical for a stable company.

3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.

4. Consistency of the profitability

5. Predictability Rank


Bide Pharmatech Co Profitability Rank Related Terms

Thank you for viewing the detailed overview of Bide Pharmatech Co's Profitability Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Bide Pharmatech Co (SHSE:688073) Business Description

Traded in Other Exchanges
N/A
Address
No. 128, Xiangyin Road, Room 101, Block A, Building 11, Yangpu District, Shanghai, CHN, 200433
Bide Pharmatech Co Ltd is engaged in the research and development, design, production and sales of drug molecular building blocks.

Bide Pharmatech Co (SHSE:688073) Headlines

No Headlines